{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-043384","form_type":"8-K","ticker":"SSII","cik":"0001676163","company_name":"SS Innovations International, Inc.","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.303557+00:00","generated_at":"2026-05-21T08:59:21.959532+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"SS Innovations Q1 revenue $5.1M (+40.8% YoY); net loss narrows; FDA submission planned by July 2025","bullets":["Revenue $5.1M (+40.8% YoY); gross margin 21.23% (up 121 bps); net loss $5.7M ($0.03 diluted) vs $9.8M ($0.06) in Q1 2024.","SSi Mantra installations 15 in Q1 (+66.7%), cumulative installed base 78, cumulative surgeries 3,568.","Cash $15.9M, zero long-term debt; subsequently uplisted to Nasdaq on April 25, 2025.","Plan to submit De Novo FDA application for SSi Mantra by July 2025; CE Mark possible late 2025.","Achieved world's first robotic cardiac telesurgery; gained regulatory approvals in Philippines and Ukraine."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-043384","json":"https://secwatch.observer/filing/0001213900-25-043384.json","markdown":"https://secwatch.observer/filing/0001213900-25-043384.md","text":"https://secwatch.observer/filing/0001213900-25-043384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676163/000121390025043384/0001213900-25-043384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676163/000121390025043384/ea0242229-8k_ssinnov.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T08:59:21.959532+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}